[Treatment of dermatomycosis with naftifin. Therapeutic effectiveness following once and twice daily administration].
D000328:Adult; D000499:Allylamine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000588:Amines / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003881:Dermatomycoses / Q000188:drug therapy*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008825:Miconazole / Q000627:therapeutic use
D000588:Amines; D000935:Antifungal Agents; D000499:Allylamine; C029178:naftifine; D008825:Miconazole
Dermatomykosebehandlung mit Naftifin. Therapeutische Wirksamkeit nach einmal und zweimal täglicher Applikation.